<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39558250</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>18</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2377</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>18</Day></PubDate></JournalIssue><Title>BMC neurology</Title><ISOAbbreviation>BMC Neurol</ISOAbbreviation></Journal><ArticleTitle>Cognitive impact and brain structural changes in long COVID patients: a cross-sectional MRI study two years post infection in a cohort from Argentina.</ArticleTitle><Pagination><StartPage>450</StartPage><MedlinePgn>450</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12883-024-03959-8</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Long COVID is a condition characterised by persistent symptoms after a SARS-CoV-2 infection, with neurological manifestations being particularly frequent. Existing research suggests that long COVID patients not only report cognitive symptoms but also exhibit measurable cognitive impairment. Neuroimaging studies have identified structural alterations in brain regions linked to cognitive functions. However, most of these studies have focused on patients within months of their initial infection. This study aims to explore the longer-term cognitive effects and brain structural changes in long COVID patients, approximately two years post-infection, in a cohort from San Mart&#xed;n, Buenos Aires, Argentina.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a cross-sectional study involving 137 participants: 109 with long COVID symptoms and 28 healthy controls. The participants underwent an initial clinical assessment, completed a structured questionnaire and standardised scales, underwent a cognitive assessment, and had a brain MRI scan. Structural MRI images were processed via FreeSurfer and FSL to obtain volumetric measures for subcortical and cortical regions, along with regional cortical thickness. Differences between groups for these variables were analysed using ANCOVA, with permutation tests applied to correct for multiple comparisons.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Long COVID patients reported persistent cognitive symptoms such as memory problems and brain fog, with higher levels of fatigue and reduced quality of life compared to controls. Despite subjective cognitive complaints, cognitive tests did not reveal significant differences between groups, except for the TMT-A (p&#x2009;=&#x2009;0.05). MRI analysis revealed decreased volume in the cerebellum (p&#x2009;=&#x2009;0.03), lingual gyrus (p&#x2009;=&#x2009;0.04), and inferior parietal regions (p&#x2009;=&#x2009;0.03), and reduced cortical thickness in several areas, including the left and right postcentral gyri (p&#x2009;=&#x2009;0.02, p&#x2009;=&#x2009;0.03) and precuneus (p&#x2009;=&#x2009;0.01, p&#x2009;=&#x2009;0.02).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study highlights the enduring impact of long COVID on quality of life and physical activity, with specific brain structural changes identified two years post-infection. Although cognitive tests did not show clear impairment, the observed brain atrophy and significant reduction in quality of life emphasize the need for comprehensive interventions and further longitudinal studies to understand the long-term effects of long COVID on cognition and brain health.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cataldo</LastName><ForeName>Sol A</ForeName><Initials>SA</Initials><AffiliationInfo><Affiliation>Centro Universitario de Im&#xe1;genes M&#xe9;dicas (CEUNIM), Escuela de Ciencia y Tecnolog&#xed;a, Universidad Nacional de Gral. San Mart&#xed;n, Campus Miguelete, 25 de Mayo 901, San Mart&#xed;n, Buenos Aires, 1650, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Micciulli</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unidad de Neuropsicolog&#xed;a, Servicio de Neurolog&#xed;a, Hospital Interzonal General de Agudos Eva Per&#xf3;n, San Mart&#xed;n, Buenos Aires, 1650, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Margulis</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Unidad de Neuropsicolog&#xed;a, Servicio de Neurolog&#xed;a, Hospital Interzonal General de Agudos Eva Per&#xf3;n, San Mart&#xed;n, Buenos Aires, 1650, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facultad de Psicolog&#xed;a, Universidad de Buenos Aires, Ciudad Aut&#xf3;noma de Buenos Aires, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cibeyra</LastName><ForeName>Melina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Servicio de Neurolog&#xed;a, Hospital Interzonal General de Agudos Eva Per&#xf3;n, San Mart&#xed;n, Buenos Aires, 1650, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Defeo</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Centro Universitario de Im&#xe1;genes M&#xe9;dicas (CEUNIM), Escuela de Ciencia y Tecnolog&#xed;a, Universidad Nacional de Gral. San Mart&#xed;n, Campus Miguelete, 25 de Mayo 901, San Mart&#xed;n, Buenos Aires, 1650, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horovitz</LastName><ForeName>Silvina G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martino</LastName><ForeName>Anal&#xed;a</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro Universitario de Im&#xe1;genes M&#xe9;dicas (CEUNIM), Escuela de Ciencia y Tecnolog&#xed;a, Universidad Nacional de Gral. San Mart&#xed;n, Campus Miguelete, 25 de Mayo 901, San Mart&#xed;n, Buenos Aires, 1650, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melano</LastName><ForeName>Raul</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Servicio de Neurolog&#xed;a, Hospital Interzonal General de Agudos Eva Per&#xf3;n, San Mart&#xed;n, Buenos Aires, 1650, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mena</LastName><ForeName>Milagros</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Escuela de Humanidades, Universidad Nacional de Gral. San Mart&#xed;n, Campus Miguelete, 25 de Mayo y Francia, San Mart&#xed;n, Buenos Aires, 1650, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parisi</LastName><ForeName>Francisco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centro Universitario de Im&#xe1;genes M&#xe9;dicas (CEUNIM), Escuela de Ciencia y Tecnolog&#xed;a, Universidad Nacional de Gral. San Mart&#xed;n, Campus Miguelete, 25 de Mayo 901, San Mart&#xed;n, Buenos Aires, 1650, Argentina.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituto de Ciencias F&#xed;sicas (ICIFI UNSAM-CONICET), Escuela de Ciencia y Tecnolog&#xed;a, Universidad Nacional de Gral. San Mart&#xed;n, Campus Miguelete, 25 de Mayo y Francia, San Mart&#xed;n, Buenos Aires, 1650, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santoro</LastName><ForeName>Diego</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centro Universitario de Im&#xe1;genes M&#xe9;dicas (CEUNIM), Escuela de Ciencia y Tecnolog&#xed;a, Universidad Nacional de Gral. San Mart&#xed;n, Campus Miguelete, 25 de Mayo 901, San Mart&#xed;n, Buenos Aires, 1650, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarmiento</LastName><ForeName>Florencia</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Centro Universitario de Im&#xe1;genes M&#xe9;dicas (CEUNIM), Escuela de Ciencia y Tecnolog&#xed;a, Universidad Nacional de Gral. San Mart&#xed;n, Campus Miguelete, 25 de Mayo 901, San Mart&#xed;n, Buenos Aires, 1650, Argentina.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Belzunce</LastName><ForeName>Martin A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Centro Universitario de Im&#xe1;genes M&#xe9;dicas (CEUNIM), Escuela de Ciencia y Tecnolog&#xed;a, Universidad Nacional de Gral. San Mart&#xed;n, Campus Miguelete, 25 de Mayo 901, San Mart&#xed;n, Buenos Aires, 1650, Argentina. mbelzunce@unsam.edu.ar.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Complex Systems and Brain Sciences (CEMSC3), Instituto de Ciencias F&#xed;sicas (ICIFI UNSAM-CONICET), Escuela de Ciencia y Tecnolog&#xed;a, Universidad Nacional de Gral. San Mart&#xed;n, Campus Miguelete, 25 de Mayo y Francia, San Mart&#xed;n, Buenos Aires, 1650, Argentina. mbelzunce@unsam.edu.ar.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consejo Nacional de Investigaciones Cient&#xed;ficas y Tecnol&#xf3;gicas (CONICET), Godoy Cruz 2290, Godoy Cruz, Buenos Aires, 1425, Argentina. mbelzunce@unsam.edu.ar.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>FITBA-B06</GrantID><Agency>Ministerio de Producci&#xf3;n, Ciencia e Innovaci&#xf3;n Tecnol&#xf3;gica de la Provincia de Buenos Aires, Argentina</Agency><Country/></Grant><Grant><GrantID>PICT-PRH-2022-01</GrantID><Agency>Agencia Nacional de Promoci&#xf3;n Cient&#xed;fica y Tecnol&#xf3;gica, Argentina</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Neurol</MedlineTA><NlmUniqueID>100968555</NlmUniqueID><ISSNLinking>1471-2377</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001118" MajorTopicYN="N" Type="Geographic">Argentina</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="Y">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="Y">Brain</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="N">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Brain atrophy</Keyword><Keyword MajorTopicYN="N">Cognitive dysfunction</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Neuroimaging</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">Structural MRI</Keyword></KeywordList><CoiStatement><b>Declarations</b> <b>Ethics approval and consent to participate</b> The study was approved by the HIGA Eva Peron Research Bioethics Committee (OHRP registration number IRB00002792). All subjects provided written informed consent. All methods were performed in accordance with the relevant guidelines and regulations. <b>Consent for publication</b> Not applicable. <b>Competing interests</b> The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>19</Day><Hour>15</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>19</Day><Hour>0</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>18</Day><Hour>23</Hour><Minute>57</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39558250</ArticleId><ArticleId IdType="doi">10.1186/s12883-024-03959-8</ArticleId><ArticleId IdType="pii">10.1186/s12883-024-03959-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>O&#x2019;Dowd A. Covid-19: Third of people infected have long term symptoms. BMJ. 2021;373:n1626.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1626</ArticleId><ArticleId IdType="pubmed">34168002</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022 287 28, 1461&#x2013;1467 (2022).</Citation></Reference><Reference><Citation>Ayoubkhani D et al. Risk of long COVID in people infected with severe Acute Respiratory Syndrome Coronavirus 2 after 2 doses of a Coronavirus Disease 2019 Vaccine: Community-Based, matched Cohort Study. Open Forum Infect Dis 9, (2022).</Citation></Reference><Reference><Citation>Subramanian A et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 2022 288 28, 1706&#x2013;1714 (2022).</Citation></Reference><Reference><Citation>Aiyegbusi OL et al. Symptoms, complications and management of long COVID: a review. Journal of the Royal Society of Medicine vol. 114 428&#x2013;442 at https://doi.org/10.1177/01410768211032850 (2021).</Citation></Reference><Reference><Citation>Michelen M, et al. Characterising long COVID: a living systematic review. BMJ Glob Heal. 2021;6:e005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, et al. Persistent symptoms after Covid-19: qualitative study of 114 long Covid patients and draft quality principles for services. BMC Health Serv Res. 2020;20:1&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Zhang Z, Zhang Z, Wang Z, Li H. Cognitive impairment after long COVID-19: current evidence and perspectives. Front Neurol. 2023;14:1239182.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1239182</ArticleId><ArticleId IdType="pmc">10423939</ArticleId><ArticleId IdType="pubmed">37583958</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, et al. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: Effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun. 2021;94:138&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.02.021</ArticleId><ArticleId IdType="pmc">7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo MS et al. Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun 2, (2020).</Citation></Reference><Reference><Citation>Hartung TJ, et al. Fatigue and cognitive impairment after COVID-19: a prospective multicentre study. eClinicalMedicine. 2022;53:101651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101651</ArticleId><ArticleId IdType="pmc">9482331</ArticleId><ArticleId IdType="pubmed">36133318</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022. https://doi.org/10.1038/s41586-022-04569-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Crivelli L et al. Changes in cognitive functioning after COVID-19: A systematic review and meta-analysis. Alzheimer&#x2019;s and Dementia vol. 18 1047&#x2013;1066 at https://doi.org/10.1002/alz.12644 (2022).</Citation></Reference><Reference><Citation>Meinhardt J et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 2020 242 24, 168&#x2013;175 (2020).</Citation></Reference><Reference><Citation>Monje M, Iwasaki A. The neurobiology of long COVID. Neuron. 2022;110:3484&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pmc">9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med 218, (2021).</Citation></Reference><Reference><Citation>Greene C, et al. Blood&#x2013;brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment. Nat Neurosci. 2024;273(27):421&#x2013;32. (2024).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-024-01576-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimer&#x2019;s Res Ther. 2020;12:1&#x2013;3.</Citation></Reference><Reference><Citation>Zorzo C, Solares L, Mendez M, Mendez-Lopez M. Hippocampal alterations after SARS-CoV-2 infection: a systematic review. Behav Brain Res. 2023;455:114662.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2023.114662</ArticleId><ArticleId IdType="pubmed">37703951</ArticleId></ArticleIdList></Reference><Reference><Citation>Nouraeinejad A. The functional and structural changes in the hippocampus of COVID-19 patients. Acta Neurologica Belgica vol. 123 1247&#x2013;1256 at https://doi.org/10.1007/s13760-023-02291-1 (2023).</Citation></Reference><Reference><Citation>D&#xed;ez-Cirarda M, et al. Hippocampal subfield abnormalities and biomarkers of pathologic brain changes: from SARS-CoV-2 acute infection to post-COVID syndrome. eBioMedicine. 2023;94:104711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2023.104711</ArticleId><ArticleId IdType="pmc">10366393</ArticleId><ArticleId IdType="pubmed">37453364</ArticleId></ArticleIdList></Reference><Reference><Citation>Soung AL, et al. COVID-19 induces CNS cytokine expression and loss of hippocampal neurogenesis. Brain. 2022;145:4193&#x2013;201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awac270</ArticleId><ArticleId IdType="pmc">9452175</ArticleId><ArticleId IdType="pubmed">36004663</ArticleId></ArticleIdList></Reference><Reference><Citation>Yongzhi X. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue. Emerging Microbes and Infections vol. 10 266&#x2013;276 at https://doi.org/10.1080/22221751.2021.1884503 (2021).</Citation></Reference><Reference><Citation>Grobbelaar LM et al. SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: implications for microclot formation in COVID-19. Biosci Rep 41, (2021).</Citation></Reference><Reference><Citation>Turner S et al. Long COVID: pathophysiological factors and abnormalities of coagulation. Trends in Endocrinology and Metabolism vol. 34 321&#x2013;344 at https://doi.org/10.1016/j.tem.2023.03.002 (2023).</Citation></Reference><Reference><Citation>Chen TH, Chang CJ, Hung PH. Possible Pathogenesis and Prevention of Long COVID: SARS-CoV-2-Induced Mitochondrial Disorder. International Journal of Molecular Sciences vol. 24 at https://doi.org/10.3390/ijms24098034 (2023).</Citation></Reference><Reference><Citation>Nunn AVW, Guy GW, Brysch W, Bell JD, Understanding Long COVID. Mitochondrial Health and Adaptation&#x2014;Old Pathways, New Problems. Biomedicines vol. 10 at https://doi.org/10.3390/biomedicines10123113 (2022).</Citation></Reference><Reference><Citation>Nabizadeh F, et al. Neuroimaging findings of COVID-19: a systematic review on longitudinal studies. Neurol Lett. 2024;3:27&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="doi">10.61186/nl.3.1.27</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein TL. Cortical Grey matter volume depletion links to neurological sequelae in post COVID-19 long haulers. BMC Neurol. 2023;23:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-023-03049-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, et al. Cerebral micro-structural changes in COVID-19 patients &#x2013; an MRI-based 3-month follow-up study: a brief title: cerebral changes in COVID-19. EClinicalMedicine. 2020;25:100484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100484</ArticleId><ArticleId IdType="pmc">7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanabria-Diaz G, et al. Brain cortical alterations in COVID-19 patients with neurological symptoms. Front Neurosci. 2022;16:992165.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2022.992165</ArticleId><ArticleId IdType="pmc">9630324</ArticleId><ArticleId IdType="pubmed">36340780</ArticleId></ArticleIdList></Reference><Reference><Citation>Michielsen HJ et al. Psychometric qualities of a brief self-rated fatigue measure psychometric qualities of a brief self-rated fatigue measure the fatigue Assessment Scale. https://doi.org/10.1016/S0022-3999(02)00392-6</Citation></Reference><Reference><Citation>Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193&#x2013;213.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-1781(89)90047-4</ArticleId><ArticleId IdType="pubmed">2748771</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig CL, et al. International physical activity questionnaire: 12-Country reliability and validity. Med Sci Sports Exerc. 2003;35:1381&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/01.MSS.0000078924.61453.FB</ArticleId><ArticleId IdType="pubmed">12900694</ArticleId></ArticleIdList></Reference><Reference><Citation>Herdman M, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-011-9903-x</ArticleId><ArticleId IdType="pmc">3220807</ArticleId><ArticleId IdType="pubmed">21479777</ArticleId></ArticleIdList></Reference><Reference><Citation>UNESCO Institute for Statistics. International Standard Classification of Education. UNESCO Institute for Statistics 88 at https://ilostat.ilo.org/methods/concepts-and-definitions/classification-education/ (2011).</Citation></Reference><Reference><Citation>Reitan RM. The relation of the trail making test to organic brain damage. J Consult Psychol. 1955;19:393&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/h0044509</ArticleId><ArticleId IdType="pubmed">13263471</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18:643&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/h0054651</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechsler DWMS-R. Wechsler Memory Scale&#x2013;Revised: manual. 150 (1987).</Citation></Reference><Reference><Citation>Nasreddine ZS, et al. The Montreal Cognitive Assessment, MoCA: a brief Screening Tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1532-5415.2005.53221.x</ArticleId><ArticleId IdType="pubmed">15817019</ArticleId></ArticleIdList></Reference><Reference><Citation>Margulis LE, Louhau S, M. R., Ferreres AR. Baremo Del Trail making test para Capital Federal Y Gran Buenos Aires. Rev Argent Cienc Comport. 2018;10:54&#x2013;63.</Citation></Reference><Reference><Citation>Rivera D, et al. Stroop Color-Word interference test: normative data for the latin American Spanish speaking adult population. NeuroRehabilitation. 2015;37:591&#x2013;624.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/NRE-151281</ArticleId><ArticleId IdType="pubmed">26639926</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervigni M, Martino P, Alfonso G, Politis D. Montreal Cognitive Assessment (MoCA): normas para la poblaci&#xf3;n del &#xe1;rea metropolitana de Rosario, Argentina. Rev Neurol. 2022;75:51.</Citation><ArticleIdList><ArticleId IdType="pmc">10280772</ArticleId><ArticleId IdType="pubmed">35879880</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SM, et al. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. NeuroImage. 2002;17:479&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nimg.2002.1040</ArticleId><ArticleId IdType="pubmed">12482100</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SM et al. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 23 Suppl 1, (2004).</Citation></Reference><Reference><Citation>Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl. Acad. Sci. 97, 11050&#x2013;11055 (2000).</Citation></Reference><Reference><Citation>Fischl B, et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron. 2002;33:341&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0896-6273(02)00569-X</ArticleId><ArticleId IdType="pubmed">11832223</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischl B et al. Sequence-independent segmentation of magnetic resonance images. NeuroImage 23 Suppl 1, (2004).</Citation></Reference><Reference><Citation>Westfall PH, Young SS. Resampling-based multiple testing: examples and methods for P-value adjustment. New York, John Wiley &amp; Sons; 1993.</Citation></Reference><Reference><Citation>Del Brutto OH, Rumbea DA, Recalde BY, Mera RM. Cognitive sequelae of long COVID may not be permanent: a prospective study. Eur J Neurol. 2022;29:1218&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15215</ArticleId><ArticleId IdType="pubmed">34918425</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2023;401:e21&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00810-3</ArticleId><ArticleId IdType="pmc">10258565</ArticleId><ArticleId IdType="pubmed">37321233</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A, et al. Cognition and memory after Covid-19 in a large community sample. N Engl J Med. 2024;390:806&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2311330</ArticleId><ArticleId IdType="pmc">7615803</ArticleId><ArticleId IdType="pubmed">38416429</ArticleId></ArticleIdList></Reference><Reference><Citation>Walitt B et al. Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome. Nat Commun 15, (2024).</Citation></Reference><Reference><Citation>Komaroff AL, Lipkin WI. ME/CFS and Long COVID share similar symptoms and biological abnormalities: road map to the literature. Front Med. 2023;10:1187163.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1187163</ArticleId></ArticleIdList></Reference><Reference><Citation>Du Y, et al. Two-year follow-up of brain structural changes in patients who recovered from COVID-19: a prospective study. Psychiatry Res. 2023;319:114969.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2022.114969</ArticleId><ArticleId IdType="pubmed">36462292</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E, et al. 18F-FDG brain PET hypometabolism in patients with long COVID. Eur J Nucl Med Mol Imaging. 2021;48:2823&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Beuriat PA, Cristofori I, Gordon B, Grafman J. The shifting role of the cerebellum in executive, emotional and social processing across the lifespan. Behav Brain Funct. 2022;18:1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12993-022-00193-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Yokoi T et al. Involvement of the Precuneus/Posterior cingulate cortex is significant for the development of Alzheimer&#x2019;s Disease: a PET (THK5351, PiB) and resting fMRI study. Front Aging Neurosci. 10, (2018).</Citation></Reference><Reference><Citation>Karas G, et al. Precuneus atrophy in early-onset Alzheimer&#x2019;s disease: a morphometric structural MRI study. Neuroradiology. 2007;49:967&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00234-007-0269-2</ArticleId><ArticleId IdType="pubmed">17955233</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazzaniga MS, Ivry RB, Mangun GR. Cognitive neuroscience: the biology of the mind. 2nd ed. W. W. Norton: New York, NY, USA; 2002.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>